Growth Metrics

Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2016 - 2026)

Oramed Pharmaceuticals filings provide 15 years of Exchange Rate Effect readings, the most recent being -$73000.0 for Q4 2025.

  • Quarterly Exchange Rate Effect fell 3550.0% to -$73000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$30000.0 through Dec 2025, down 650.0% year-over-year, with the annual reading at -$30000.0 for FY2025, 650.0% down from the prior year.
  • Exchange Rate Effect hit -$73000.0 in Q4 2025 for Oramed Pharmaceuticals, down from $4000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $40000.0 in Q2 2025 and bottomed at -$105000.0 in Q4 2022.
  • Average Exchange Rate Effect over 5 years is -$8000.0, with a median of -$1000.0 recorded in 2024.
  • Peak annual rise in Exchange Rate Effect hit 1100.0% in 2025, while the deepest fall reached 3550.0% in 2025.
  • Oramed Pharmaceuticals' Exchange Rate Effect stood at $23000.0 in 2021, then crashed by 556.52% to -$105000.0 in 2022, then soared by 107.62% to $8000.0 in 2023, then plummeted by 125.0% to -$2000.0 in 2024, then crashed by 3550.0% to -$73000.0 in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Exchange Rate Effect are -$73000.0 (Q4 2025), $4000.0 (Q3 2025), and $40000.0 (Q2 2025).